| Literature DB >> 16814639 |
Aki Rovasalo1, Harri Tohmo, Riku Aantaa, Eija Kettunen, Riitta Palojoki.
Abstract
In this case report, even a moderate dose of dexmedetomidine, a very selective alpha(2)-adrenergic agent, resulted in a rapid response to alcohol withdrawal delirium after the standard treatment. Psychiatrists should be aware of this relatively new drug that provides advantages over clonidine, heavy sedation and secondary restraints. Dexmedetomidine should be further evaluated in the treatment of specific forms of aggressive behavior and complicated withdrawal states.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16814639 DOI： 10.1016/j.genhosppsych.2006.03.002
Source DB: PubMed Journal: Gen Hosp Psychiatry ISSN： 0163-8343 Impact factor: 3.238